This study extends our knowledge about the regulation of HIF-2α at the translational level by miRNAs and eIF4E, and suggests that miR-558 and eIF4E may be of potential values as novel therapeutic targets for human NB. This evidence concerns the gene EPAS1 and neuroblastoma.